Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab Window Before Chemotherapy in Pediatric Mature B-NHL or B-ALL
DRKS00000908Phase 2Active, not recruiting
- Sponsor
- Universitäts-Kinderklinik Münster, Pädiatrische Hämatologie und Onkologie
- Start
- Mar 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 2
01
Overview
Phase 2, single-arm trial of rituximab in mature B-cell lymphoma and B cell acute lymphoblastic leukemia (B-ALL), sponsored by Universitäts-Kinderklinik Münster, Pädiatrische Hämatologie und Onkologie. Started Mar 2012; status: active, not recruiting.
02
Drugs
rituximab
03
Conditions
mature B-cell lymphomaB cell acute lymphoblastic leukemia (B-ALL)
Beyond the preview
Go deeper on DRKS00000908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000908.